Latest Breaking News On - France french national institute of health - Page 3 : comparemela.com

QUANTUM GENOMICS: Quantum Genomics Announces the Publication of New Scientific Article in Biomedecine et Pharmacotherapy which further strengthen its Phase III development plan in difficult to treat and resistant hypertension

(1) Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat difficult to treat/resistant hypertension and heart failure, announces the publication in Biomedecine &Pharmacotherapy of a new scientific peer-reviewed article reporting the efficacy of firibastat in combination with enalapril and hydrochlorothiazide in an experimental model of salt-sensitive hypertension (the DOCA-salt hypertensive rat). The article, entitled Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats is available online on the website of the journal Biomedecine -& Pharmacotherapy (Biomedicine & Pharmacotherapy - Journal - Elsevier DOI: 10.1016/j.biopha.2021.111682). The reported data demonstrate that the hypotensive effect induced in hypertensive DOCA-salt rat with a once-daily treatment

New yorkUnited statesFrance generalCatherine llorens cortesFabrice balavoineMike tattoryFrance french national institute of healthDevelopment of quantum genomicsScientific centre for national researchDescartes universityQuantum genomicsEuronext growthVice president researchParis descartes universityFrench national instituteMedical research

QUANTUM GENOMICS: Quantum Genomics Secures 3 Million euros Non-dilutive Financing

€1.5 million guaranteed by the French government (PGE) and granted by BNP bank €1.5 million innovation and R&D loan granted by Bpifrance Funding will allow for acceleration of R&D programs Quantum

New yorkUnited statesFrance generalJean philippe milonCatherine llorens cortesMike tattoryFrance french national institute of healthScientific centre for national researchDescartes universityEuronext growthChief executive officerQuantum genomicsParis descartes universityFrench national instituteMedical researchScientific centre

Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart . Quantum GenomicsApril 21, 2021 GMT PARIS, April 21, 2021 (GLOBE NEWSWIRE) Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, will present top-line results from its QUORUM study of firibastat in heart failure post myocardial infarction at the European Society of Cardiology (ESC) meeting in August 2021. These results will also be published in a peer-review journal.

New yorkUnited statesFrance generalUnited kingdomGilles montalescotCatherine llorens cortesMike tattoryFrance french national institute of healthData monitoring committeeScientific centre for national researchDescartes universityScientific communicationsEuropean society of cardiologyEuropean society congressEuronext growthEuropean society

QUANTUM GENOMICS: Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting

QUANTUM GENOMICS: Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFrance generalUnited kingdomGilles montalescotCatherine llorens cortesMike tattoryFrance french national institute of healthData monitoring committeeScientific centre for national researchDescartes universityScientific communicationsEuropean society of cardiologyEuropean society congressQuantum genomicsEuronext growth

QUANTUM GENOMICS: Quantum Genomics announces the end of its collaboration with Chinese Pharma Qilu in the development and commercialization of firibastat in China

QUANTUM GENOMICS: Quantum Genomics announces the end of its collaboration with Chinese Pharma Qilu in the development and commercialization of firibastat in China
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFrance generalPharma qiluCatherine llorens cortesMike tattoryFrance french national institute of healthScientific centre for national researchDescartes universityScientific communicationsQuantum genomicsChinese pharma qiluEuronext growthQilu pharmaceuticalParis descartes universityFrench national institute